Presidio Medical is a medtech company that develops a transformational neuromodulation platform.
Presidio Medical has raised $72.0M in total funding. The most recent round was Series C. The last funding was announced in June 2023.
Presidio Medical's investors include Deerfield, Shangbay Capital, Action Potential Venture Capital, Invus Opportunities.
Presidio Medical is headquartered in South San Francisco, United States.
Presidio Medical is a medtech company that develops a transformational neuromodulation platform.
Presidio Medical is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Presidio Medical — Funding & Investors." VCBacked, June 26, 2023, https://www.vcbacked.co/company/presidio-medical. Accessed October 28, 2026.
VCBacked. (2023). Presidio Medical — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/presidio-medical
{{cite web |title=Presidio Medical — Funding & Investors |url=https://www.vcbacked.co/company/presidio-medical |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated